Background A glioblastoma is a fatal type of brain tumour for which the standard of care is
maximum surgical resection followed by chemoradiotherapy, when possible. Age is an …

Background This is an updated version of the original Cochrane Review published in Issue
8, 2016. High grade glioma (HGG) is a rapidly growing brain tumour in the supporting cells …

We explored predictive factors of pseudoprogression (PsP) and its impact on prognosis in a
retrospective series of uniformly treated glioblastoma patients. Patients were classified as …

The diagnosis of glioblastoma (GBM) often carries a dismal prognosis, with a median
survival of 14.6 months. A particular challenge is the diagnosis of GBM in the elderly …

Although current treatment advances prolong patient survival, treatment for glioblastoma
(GBM) in the elderly has become an emerging issue. The definition of “elderly” differs across …

Background: Glioblastoma (GBM) is a very poor-prognosis brain tumor. To date, maximal
excision followed by radiochemotherapy, in 30 fractions, is the standard approach. Limited …

Target population These recommendations apply to adult patients diagnosed with newly
diagnosed glioblastoma. Question 1 In adult patients (aged 65 and under) with newly …

Background Glioblastoma is an aggressive disease with a defined standard of care offering
crucial survival benefits. Disparities in care may influence treatment decisions. This study …

Introduction: Poor outcomes in glioma patients indicate a need to determine prognostic
indicators of survival to better guide patient specific treatment options. While preoperative …

Background The optimization of the management for elderly glioblastoma patients is crucial
given the demographics of aging in many countries. We report the outcomes for a “real-life” …